Pfizer Inc (PFE MU) stock market data APIs
€21.3945
0.02(0.1%)
as of July 4, 2025
Try our APIs with
free plan!
Pfizer Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for PFE.MU.
Prev. Close
21.3945
Open
21.4124
High
21.4124
Low
21.3945
52 wk Range
18.4884-27.4353
Market Cap
262 316 M
Dividends (Yield)
0.0341
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pfizer Inc data using free add-ons & libraries
Get Pfizer Inc Fundamental Data
Pfizer Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pfizer Inc News
New
HER2+ Breast Cancer Market Analysis and Forecasts Report 2025-2035 | Emerging Markets and Players Shape Future of HER2-Positive Cancer Solutions
Company Logo The global HER2-positive breast cancer market is rapidly evolving due to rising prevalence and demand for targeted therapies. HER2-positive breast cancer, characterized by overexpression...
Trending tickers: TripAdvisor, Bitmine, WolfSpeed, BYD and AstraZeneca
TripAdvisor (TRIP) Shares in TripAdvisor (TRIP) were in the red in after hours trading after surging by 16% in Thursday's session as it was revealed by the Wall Street Journal that activist investor ...
Pfizer Advances HYMPAVZI After Successful Hemophilia Trial Results
Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared that the Phase 3 BASIS research results showed that its medication HYMPAVZI ...
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. (NYSE:PFE) executive, in connection with an investigation into claims that the company intentionally delayed the...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
